NPPA extends knee implant price ceiling by one year till November 2026

The NPPA has extended the knee implant price cap despite industry requests to remove or relax it, citing rising costs and innovation needs, as the regulator prioritises affordability for patients

The National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation for orthopaedic knee implants used in knee replacement systems another year, that is, till November 2026.

 

In a notification dated September 15, the drug price regulator said the fixed price ceiling shall remain in force for orthopaedic knee implants for a further period of up to one year, that is, till November 15, 2025, or further order, whichever comes earlier.

 

Why did the NPPA extend the price ceiling?

 

The decision, taken at the 139th meeting of the authority on November 14, comes at a time when several manufacturers